Bioregenx (BRGX) Shares Outstanding (2021 - 2026)

Bioregenx has reported Shares Outstanding for 6 years, with the latest figure at $971.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 1.17% year-over-year to $971.6 million; the trailing twelve-month figure through Mar 2026 stood at $971.6 million (up 1.17% YoY), and the FY2024 full-year result was $3800.0, changed 0.0% from the prior year.
• Shares Outstanding for Q1 2026 stood at $971.6 million, up from $3800.0 in the prior quarter.
• The five-year high for Shares Outstanding was $971.6 million in Q1 2026, with the low at $3800.0 in Q2 2023.
• Average Shares Outstanding over 5 years is $630.0 million, with a median of $770.2 million recorded in 2023.
• Year-over-year, Shares Outstanding sank 100.0% in 2024 and soared 25293482.95% in 2025.
• Tracing BRGX's Shares Outstanding over 5 years: stood at $759.7 million in 2022, then slumped by 100.0% to $3800.0 in 2023, then changed by 0.0% to $3800.0 in 2024, then changed by 0.0% to $3800.0 in 2025, then soared by 25567667.97% to $971.6 million in 2026.
• The last three Shares Outstanding figures came in at $971.6 million (Q1 2026), $3800.0 (Q4 2025), and $962.0 million (Q3 2025), per Business Quant data.

Peer Comparison